We're set to gap up this morning. About an hour ago the QQQQ got within a few cents of yesterday's high. I'm watching for that level to break before getting aggressively long.
Here are some stocks (besides those on the gappers lists below) that have my attention this morning:
MFLX - $56 tgt from Needham
CDWC - earnings, breaking under its 50 DMA
CRM - lost a client to Siebel
FCEL - first sale in Japan
Potential swing trades:
See one of the recent 'Chart Reading' posts for some potential swing candidates.
Potential day trades:
(From Briefing.com)
Gapping Down
Gapping down on disappointing earnings/guidance: MFE -14% (also multiple downgrades), ADTN -10%, AV -8.2% (also downgrades from Citigroup and Piper), MMM -2.6%, LSS -2.6%, DD -2%, JNJ -1.9%, TXN -1% (also Soleil downgrade)... Other News: SUF -16% (negative SmartMoney.com story), CRIS -22% (clinical data), HL -17%, TRCA -6.6%, SYMC -4.4% (in sympathy with MFE; vice chairman steps down unexpectedly), GTE -3.6%, NUVO -3.6% (stock offering), RTEC -2.6% (KLAC withdraws AUGT offer; RTEC had made an offer for AUGT), VOD -1.8% (reports Q4 customer growth), SHPGY -1.4%.
Gapping Up
Gapping up on strong earnings/guidance: ARBA +18% (also JMP Sec upgrade), LXK +9%, ANLY +18% (guidacne only), LIFC +8.2% (guidance only), SWFT +8.2%, LAB +6%, HOLX +5.8%, HW +5.5%, IMCL +4%, COH +4%, ET +3.8%, CRXL +2.8%, AKS +2.5%, EMC +1.8%, MCD +1.4%... Other News: IDCC +20% (announces deal with LG Electronics; First Albany upgrade), CPST +15% (receives GSA approval), CYTO +8.5% (clinical data), OSUR +5.7% (Johns Hopkins implements HIV screening program), OS +4.8% (Mad Money mention), DCN +3.2%, KND +3.2%, GILD +2.4% (Mad Money mention), PIXR +2% (closer to a deal with DIS), STX +1.8% (Mad Money mention), GOOG +1.7%, KO +1.6% (Merrill upgrade), SNDK +1.3%, YHOO +1.1%... Under $3: WGATE +17% (reports Q3), AXYX +13% (clinical data), VTSS +8.1%, GNTA +6.8% (clinical trial started), SATC +5% (contract).
Disclaimer & How I use this list
MRK's CEO says, "Looking to buy larger biotech companies; takevover tgts must bring rev, late stage pdts" (according to Briefing).
If you were MRK, who would you buy? MYOG, CELG, KOSP, VPHM, VRTX, IMCL, AMLN, PANC, RNVS, ZGEN, BCRX? Or, one of the big boys like GENZ, GILD, or BIIB? WHO?